Bromocriptine Shortage Update: What Patients Need to Know in 2026

If you or a family member takes bromocriptine (Parlodel or Cycloset), you may be wondering whether there is an active drug shortage — and what it means for filling your prescription. Here's what patients need to know in 2026.

Is Bromocriptine in Shortage Right Now?

As of 2026, generic bromocriptine mesylate (Parlodel formulation) is not listed as an active shortage on the FDA Drug Shortage Database. Multiple generic manufacturers supply the U.S. market with bromocriptine tablets and capsules, which helps maintain overall national supply.

However, Cycloset (0.8 mg, brand only) continues to be harder to find due to limited distribution. Since there is no generic for Cycloset, patients relying on this formulation for type 2 diabetes management are more vulnerable to localized stock-outs.

Why Patients Still Experience Difficulty Finding Bromocriptine

Even without an FDA-declared national shortage, many patients report that their local pharmacies don't stock bromocriptine regularly. The reasons include:

Low prescription volume: Bromocriptine is prescribed for relatively specialized conditions. Pharmacies order based on demand, so lower-volume drugs are often held in minimal quantities.

Complex supply chain: Bromocriptine is derived from ergot alkaloids, which have a complex synthesis and are sourced from a limited number of raw material suppliers. Any disruption can cause regional gaps.

Brand-only Cycloset: Without a generic option, Cycloset is less widely stocked than generic bromocriptine, particularly at smaller independent pharmacies.

Multiple non-interchangeable formulations: A pharmacy stocking Cycloset cannot fill a Parlodel prescription and vice versa, creating gaps for specific patients.

Historical Context: Has Bromocriptine Ever Been in a Declared Shortage?

Bromocriptine has not been the subject of frequent FDA-declared shortages in recent years. This reflects the fact that multiple generic manufacturers supply the market. However, individual manufacturer production issues or distributor disruptions can still cause temporary regional gaps — situations the FDA monitors through its Drug Shortage Database.

What Conditions Does the Shortage Affect Most?

Patients most likely to be affected by bromocriptine availability issues are:

Type 2 diabetes patients on Cycloset (brand-only, limited stocking)

Patients in rural areas with fewer pharmacy options

Patients requiring higher doses (e.g., acromegaly or Parkinson's) who need larger quantities per fill

5 Practical Steps Patients Can Take Right Now

Refill early: Request your refill 7-10 days before you run out so you have time to locate the medication if your regular pharmacy is out of stock.

Check more than one pharmacy: Availability varies significantly by location. A pharmacy two miles away may have it when your regular one doesn't.

Use medfinder: medfinder calls local pharmacies and texts you results — no hold music required.

Consider mail-order: A 90-day mail-order supply is one of the most reliable ways to avoid interruptions in therapy.

Talk to your doctor about alternatives: If you're consistently struggling to find your medication, your prescriber can discuss whether a clinically equivalent alternative is appropriate.

Where to Monitor Bromocriptine Availability

FDA Drug Shortage Database — check for active or resolved shortages

ASHP Drug Shortage Resource Center — a comprehensive resource for healthcare professionals and patients

medfinder — call pharmacies near you to locate your exact medication in stock

If you're a healthcare provider trying to help patients find bromocriptine, read our provider-specific shortage guide for clinical guidance and pharmacy communication tips.